検索
Translational Development Acquisition Corp
TDACUウォッチリストに追加
11.310USD
0.0000.00%
終値 07/02, 13:00（ET）15分遅れの株価
234.63M時価総額
--直近12ヶ月PER
詳細情報 Translational Development Acquisition Corp 企業名
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Translational Development Acquisition Corpの企業情報
企業コードTDACU
会社名Translational Development Acquisition Corp
上場日Dec 23, 2024
最高経営責任者「CEO」Hoffman (Michael B)
従業員数- -
証券種類Unit
決算期末- -
本社所在地52 E 83Rd St.
都市NEW YORK
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号10028
電話番号14132042769
ウェブサイト
企業コードTDACU
上場日Dec 23, 2024
最高経営責任者「CEO」Hoffman (Michael B)
Translational Development Acquisition Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
よくある質問
Translational Development Acquisition Corpの上位5名の株主は誰ですか？
Translational Development Acquisition Corpの上位5名の株主は以下のとおりです。Mr. Michael B. Hoffman
Translational Development Acquisition Corp（TDACU）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Translational Development Acquisition Corpの株式を保有している機関は47社あり、保有株式の総市場価値は約958.07Kで、全体の5.55%を占めています。2025Q4と比較して、機関の持ち株は-14147897.00増加しています。